Ethics of cancer clinical trials in low-resource settings.
作者信息
Joffe Steven, Miller Franklin G
机构信息
Steven Joffe, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; and Franklin G. Miller, National Institutes of Health, Bethesda, MD.
出版信息
J Clin Oncol. 2014 Oct 1;32(28):3192-6. doi: 10.1200/JCO.2014.56.9780. Epub 2014 Sep 2.
Abstract
摘要
相似文献
1
Ethics of cancer clinical trials in low-resource settings.资源匮乏地区癌症临床试验的伦理问题。
J Clin Oncol. 2014 Oct 1;32(28):3192-6. doi: 10.1200/JCO.2014.56.9780. Epub 2014 Sep 2.
2
Clinical trial ethics: one standard does not fit all.临床试验伦理：一种标准并不适用于所有情况。
J Clin Oncol. 2015 Apr 20;33(12):1413-4. doi: 10.1200/JCO.2014.59.5371. Epub 2015 Feb 23.
3
Reply to S. Gupta et al.对S. 古普塔等人的回复
J Clin Oncol. 2015 Apr 20;33(12):1414. doi: 10.1200/JCO.2014.60.1096. Epub 2015 Feb 23.
4
StatBite: Key findings from the "Impact on clinical research of European legislation" report.数据摘要：《欧洲立法对临床研究的影响》报告的主要发现。
J Natl Cancer Inst. 2010 Mar 3;102(5):293. doi: 10.1093/jnci/djq046. Epub 2010 Feb 19.
5
The ancillary-care obligations of medical researchers working in developing countries.在发展中国家工作的医学研究人员的辅助医疗义务。
PLoS Med. 2008 May 20;5(5):e90. doi: 10.1371/journal.pmed.0050090.
6
Unacceptable practice in our field.我们这个领域中不可接受的做法。
Bone Joint J. 2020 Nov;102-B(11):1429-1430. doi: 10.1302/0301-620X.102B11.BJJ-2020-1818.
7
Should ethics standards for overseas trials get a makeover?: Transparency in overseas medical research has improved, but several issues concerning ethics of protections for trial participants remain unsolved.海外试验的伦理标准应该进行修订吗？：海外医学研究的透明度有所提高，但在试验参与者保护伦理方面的几个问题仍未得到解决。
Ann Neurol. 2013 Jul;74(1):A7-A10. doi: 10.1002/ana.23961.
8
The impact of selective publication on clinical research in pain.选择性发表对疼痛临床研究的影响。
Pain. 2008 Dec;140(3):401-404. doi: 10.1016/j.pain.2008.10.026. Epub 2008 Nov 11.
9
Research ethics. Beyond access vs. protection in trials of innovative therapies.研究伦理。创新疗法试验中超越准入与保护的议题。
Science. 2010 May 14;328(5980):829-30. doi: 10.1126/science.1189369.
10
[Quicker ethical trials with correctly filled in forms].
Lakartidningen. 2005;102(35):2428; author reply 2428.
引用本文的文献
1
Global efforts toward the cure of childhood acute lymphoblastic leukaemia.全球治愈儿童急性淋巴细胞白血病的努力。
Lancet Child Adolesc Health. 2018 Jun;2(6):440-454. doi: 10.1016/S2352-4642(18)30066-X. Epub 2018 Mar 30.
2
Ethics of Clinical Trials in Low-Resource Settings: Lessons From Recent Trials in Cancer Medicine.资源匮乏地区临床试验的伦理：癌症医学近期试验的经验教训。
J Glob Oncol. 2015 Dec 23;2(1):1-3. doi: 10.1200/JGO.2015.000885. eCollection 2016 Feb.
3
Ethical Issues in the Management of Renal Cell Carcinoma.肾细胞癌管理中的伦理问题
Kidney Cancer J. 2015;13(1):10-17.
4
Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.通过合作努力治愈所有患癌儿童：儿科肿瘤学作为一项全球挑战
J Clin Oncol. 2015 Sep 20;33(27):3065-73. doi: 10.1200/JCO.2014.60.6376. Epub 2015 Aug 24.
5
The cervix cancer research network: increasing access to cancer clinical trials in low- and middle-income countries.宫颈癌研究网络：增加低收入和中等收入国家癌症临床试验的可及性
Front Oncol. 2015 Feb 19;5:14. doi: 10.3389/fonc.2015.00014. eCollection 2015.
本文引用的文献
1
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India.初级卫生工作者进行阴道镜检查（VIA）筛查的效果：印度孟买的随机对照研究。
J Natl Cancer Inst. 2014 Mar;106(3):dju009. doi: 10.1093/jnci/dju009. Epub 2014 Feb 22.
2
World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.《世界医学协会赫尔辛基宣言：涉及人类受试者的医学研究伦理原则》
JAMA. 2013 Nov 27;310(20):2191-4. doi: 10.1001/jama.2013.281053.
3
Lapatinib versus placebo added to paclitaxel in first-line human epidermal growth factor receptor 2-positive metastatic breast cancer: ethical lessons not learned from Africa.拉帕替尼与安慰剂加紫杉醇用于一线人表皮生长因子受体2阳性转移性乳腺癌的疗效对比：未从非洲吸取的伦理教训
J Clin Oncol. 2013 Nov 20;31(33):4271. doi: 10.1200/JCO.2013.51.0289. Epub 2013 Oct 14.
4
Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.拉帕替尼联合紫杉醇治疗人表皮生长因子受体 2 过表达转移性乳腺癌的随机试验。
J Clin Oncol. 2013 Jun 1;31(16):1947-53. doi: 10.1200/JCO.2011.40.5241. Epub 2013 Mar 18.
5
Equipoise: asking the right questions for clinical trial design.均衡：为临床试验设计提出正确的问题。
Nat Rev Clin Oncol. 2012 Jan 10;9(4):230-5. doi: 10.1038/nrclinonc.2011.211.
6
A framework for risk-benefit evaluations in biomedical research.生物医学研究中风险-效益评估的框架。
Kennedy Inst Ethics J. 2011 Jun;21(2):141-79. doi: 10.1353/ken.2011.0007.
7
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
8
Rethinking the responsiveness requirement for international research.重新思考国际研究中的响应性要求。
Lancet. 2009 Sep 5;374(9692):847-9. doi: 10.1016/S0140-6736(09)60320-2.
9
HPV screening for cervical cancer in rural India.印度农村地区宫颈癌的人乳头瘤病毒筛查
N Engl J Med. 2009 Apr 2;360(14):1385-94. doi: 10.1056/NEJMoa0808516.
10
International ethical guidelines for biomedical research involving human subjects.涉及人类受试者的生物医学研究国际伦理准则。
Bull Med Ethics. 2002 Oct(182):17-23.
Zotero 插件